Sg Americas Securities, LLC Kronos Bio, Inc. Transaction History

Sg Americas Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$1.34 - $2.62 $5,819 - $11,378	4,343 Added 32.93%	17,532 $26,000
Q4 2022 Feb 02, 2023	SELL	$1.44 - $3.44 $184,213 - $440,065	-127,926 Reduced 90.65%	13,189 $21,000
Q3 2022 Oct 31, 2022	SELL	$3.35 - $5.55 $23,781 - $39,399	-7,099 Reduced 4.79%	141,115 $473,000
Q2 2022 Jul 29, 2022	BUY	$3.12 - $7.52 $66,671 - $160,694	21,369 Added 16.85%	148,214 $539,000
Q1 2022 Apr 29, 2022	SELL	$6.26 - $14.42 $371,086 - $854,803	-59,279 Reduced 31.85%	126,845 $917,000
Q4 2021 Feb 07, 2022	BUY	$11.35 - $21.18 $1.85 Million - $3.45 Million	162,763 Added 696.73%	186,124 $2.53 Million
Q3 2021 Nov 01, 2021	BUY	$18.17 - $24.7 $424,469 - $577,016	23,361 New	23,361 $490,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $48.8M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.